Clinical Trial Update: A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is recruiting to evaluate the effectiveness and safety of AK0529 for treating respiratory syncytial virus infections in hospitalized in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• AK0529 (AK0529)

Snippet

Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. | Conditions: Respiratory Synctial Virus Infections | Phase 3 | Status: RECRUITING